Related Organization(s)

You just read:

Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient® (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening Procedure

News provided by

Eli Lilly and Company

Aug 26, 2012, 02:01 ET